Recombinant Rat Il9 protein
Cat.No. : | Il9-2171R |
Product Overview : | Recombinant Rat Il9 protein was expressed in Escherichia coli. |
- Specification
- Gene Information
- Related Products
- Download
Description : | Cytokine involved in mast cell and megakaryioblastic leukemic cell proliferation and hemopoietic cell growth; human homolog may be involved in Hodgkins disease, malignant lymphoma, and asthma. |
Source : | E.coli |
Species : | Rat |
Form : | Lyophilized from a 0.2μm filtered concentrated solution in PBS, pH 7.4. |
Bio-activity : | Fully biologically active when compared to standard. The ED50 as determined by a cell proliferation assay using murine TS1 cells is less than 10 ng/ml, corresponding to a specific activity of > 1.0 × 10⁵ IU/mg. |
Molecular Mass : | Approximately 14.3 kDa, a single non-glycosylated polypeptide chain containing 127 amino acids. |
Protein length : | 127 |
AA Sequence : | MQRCSTSWGIQHTSYLIENLKDDPS SKCSCSANVTSCLCLPIPSDDCTTP CFQEGMSQVTNATQQSKFSPFFFRV KRIVETLKSNKCQFFSCEKPCNQTT AGNTVSFLKSLLKTFQKTEVQVQRS RA |
Endotoxin : | Less than 0.1 EU/µg of rRtIL-9 as determined by LAL method. |
Purity : | >97% by SDS-PAGE and HPLC analysis. |
Storage : | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 centigrade as supplied. 1 month, 2 to 8 centigrade under sterile conditions after reconstitution. 3 months, -20 to -70 centigrade under sterile conditions after reconstitution. |
Reconstitution : | We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤-20 centigrade. Further dilutions should be made in appropriate buffered solutions. |
Tag : | Non |
Gene Name : | Il9 |
Official Symbol : | Il9 |
Synonyms : | IL9; interleukin 9; interleukin-9; |
Gene ID : | 116558 |
mRNA Refseq : | NM_001105747 |
Protein Refseq : | NP_001099217 |
UniProt ID : | D4A8I9 |
Products Types
◆ Recombinant Protein | ||
IL9-2327H | Recombinant Human IL9 Protein, His-tagged | +Inquiry |
IL9-3566H | Recombinant Human IL9 protein, His-SUMO-tagged | +Inquiry |
IL9-1539M | Recombinant Mouse IL9 protein, His-tagged | +Inquiry |
IL9-218H | Recombinant Active Human IL9 Protein, His-tagged(N-ter) | +Inquiry |
IL9-4743H | Recombinant Human IL9 protein, hFc-tagged | +Inquiry |
◆ Lysates | ||
IL9-618HCL | Recombinant Human IL9 cell lysate | +Inquiry |
Related Gene
Not For Human Consumption!
Inquiry
- Reviews
- Q&As
Customer Reviews (3)
Write a reviewThe anti-interference ability of IL9 was excellent in Western blot, which avoided the interference problem in the experiment.
This protein has high catalytic efficiency, high safety and high expression level, and is a precious resource in the field of scientific research.
The reproducibility of IL9 is very good, which can reduce the error in the experiment and improve the repeatability of the experiment.
Q&As (6)
Ask a questionSeveral clinical trials are currently underway to evaluate the safety and effectiveness of IL9 in treating conditions such as asthma and allergies. However, the research is still in its early stages and more data are needed.
IL9 can be synthesized in the laboratory by biotechnological methods. Before clinical use, it needs to go through strict quality control and testing.
By binding to specific receptors, IL9 can activate relevant signaling pathways and regulate the development and function of immune cells. It can affect the activity of a variety of immune cells, such as T cells and macrophages.
IL9 has cross-action with other cytokines, which can regulate the expression and function of each other. For example, IL9 can promote the production of IL4 and IL13, and IL4 and IL13 can also promote the secretion of IL9.
IL9 can be used to treat certain inflammatory diseases, such as asthma and skin allergies. It can regulate the response of the immune system and reduce the symptoms of related diseases.
The mechanism of action of IL9 in asthma treatment is not fully understood, but studies have shown that it can reduce the infiltration of inflammatory cells and the release of inflammatory mediators, thereby reducing the symptoms of asthma.
Ask a Question for All Il9 Products
Required fields are marked with *
My Review for All Il9 Products
Required fields are marked with *
Inquiry Basket